Zolmitriptan (a 5-HT[sub 1B/1D] receptor agonist with central action) does not increase symptoms in obsessive compulsive disorder.

Autor: Boshuisen, M.L., den Boer, J.A.
Zdroj: Psychopharmacology. 2000, Vol. 152 Issue 1, p74. 6p.
Databáze: Academic Search Ultimate